维普中文期刊产品整合服务
23篇 您的检索式:作者名="Borchmann P"
    题名 作者 年代 出处 被引量
1Phase 1 trial of the novel bispecific molecule H22xKi- 4 in patients with refractory Hodgkin lymphoma显示文摘Borchmann P Schnell R Fuss I 2002Blood2002,100,9:1
2Immunotherapy of Hodgkins lymphoma显示文摘BORCHMANN P SCHNELL R ENGERT A 2005Haemstol Suppl2005,5,66:1
3New drugs in the treatment of Hodgkin's disease 显示文摘BORCHMANN P SCHNELL R DIEHL V 1998Ann Oncol1998,9,5:1
4Targeted BEACOPP variants in patients with newly diagnosed advanced stage classical Hodgkin lymphoma:interim results of a randomized phase Ⅱ study显示文摘Borchmann P Eichenauer DA Pluetschow A 2013Blood2013,122,:1
5Eight cycles of escalated-dose BEACOPP compared with four cycles of escala- ted-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with ad- vance&stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group显示文摘Borchmann P Haverkamp H Diehl V 2011J Clin Oncol2011,29,32:1
6Early intensification treatment approach in advanced-stage Hodgkin lymphoma 显示文摘Borchmann P 2014Hematol Oncol Clin North Am2014,28,1:1
7Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia:results of a phase Ⅱ trial显示文摘Elter T Borchmann P Schulz H 2005J Clin Oncol2005,23,28:1
8Eight cycles of escalated- dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP withor without radio- therapy in patients with advanced-stage hodgkin' s lymphoma: final a- nalysis of the HD12 trial of the German I-Iodgkin Stud Group 显示文摘Borchmann P Haverkamp H Diehl V 2011J Clin Oncol2011,29,32:1
9Dose-escalation with BEACOPP escalated is superior to ABVD in the combined-modality treatment of early unfavorable Hodgkin lymphoma:final analysis of the German Hodgkin Study Group HD14 trial显示文摘Engert A Borchmann P Pluetschow A 2010Blood2010,116,:1
10Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin's lymphoma显示文摘Schnell R Borchmann P Staak JO 2003Ann Oncol2003,14,5:1
11Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trial显示文摘ELTER T BORCHMANN P SCHULZ H 2005J Clin Oncol2005,23,28:1
12Immunotherapy of Hodgkin' s lymphoma显示文摘Borchmann P Schnell R Engert A 2005Eur J Haematol2005,75,66:1
13phase H study of the new aza-anthracenidone,BBR2778,in patients with relapsed aggressive non-Hodgkin, slymphomas显示文摘BORCHMANN P MORSCHHAUSER F PARRY A etal 2003Haematolgia2003,88,:1
14Clinical evaluation of riein Achain immunotoxins in patients with Hodgkin' s lymphoma 显示文摘Schnell R Borchmann P Staak J O 2003Ann Oncol2003,14,5:1
15Idarubicin:a brief overview on pharmacology and clinical use显示文摘Borchmann P Hübel K Schnell R 0,,:1
16Dose-intensified combined followed by 2 cycles of ABVD and involvad field radiotherapy (IF-RT) is superior to 4 cycles of ABVD and IFRT in patients with early unfavouable Hodgkin lymphoma (HL):an analysis of the German Hodgkin Study Group (GHSG) HD14 Trial显示文摘Borchmann P Engert A Pluetschow A 2008Blood2008,112,11:1
17Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin's lymphoma显示文摘Schnell R Borchmann P Staak J 2003Ann Oncol2003,14,5:1
18Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trial显示文摘Elter T Borchmann P Schulz H 2005J Clin Oncol2005,23,28:1
19Combined modality treatment with intensified chemotherapy and dose -reduced involved field radiotherapy in patients with early unfavorable Hodgkin lymphoma(HL):final analysis of the German Hodgkin Study Group(GHSG)HD11 trial显示文摘Borchmann P Diehl V Goergen H 2009Blood2009,114,:1
20Dose intensity of chemo- therapy in patients with relapsed Hodgkin's lymphoma显示文摘Josting A Muller H Borchmann P 2010J Clin Oncol2010,28,34:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费